(Total Views: 75)
Posted On: 04/01/2019 10:55:40 AM
Post# of 21197
$TGTX News Article - TG Therapeutics Reports Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 2019 AACR Annual Meeting https://marketwirenews.com/news-releases/tg-t...23178.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
